RO60 and synovial sarcoma: The investigators found that SLE was prevalent in patients with anti-Ro60-positive and anti-Ro52-negative antibodies, whereas in patients with both anti-Ro60- and anti-Ro52-positive antibodies, SS was the predominant diagnosis.